From left, SMU Cox Graduate Entrepreneurship Club leaders:
President Valecia Harris, VP of Entrepreneurship Community Outreach Matt Hauck, and VP of Fundraising/ Sponsorship Development Annabel Reeves.
Students and recent alumni of Southern Methodist University will have the opportunity to be a part of an "intense and enriching" 6-month program—and a chance to compete for funding.
Dallas' own Kanarys, Inc. and Zirtue are joining the three-day Rise of the Rest Virtual Tour: Equity Edition. This year's speakers include AOL co-founder Steve Case and NBA and NHL sports team owner Ted Leonsis.
Fort Worth's Neuro Rehab VR, pitched by Veena Somareddy, won in a startup competition that rounded out the day.
The event, originally intended as a hosted event in Dallas, was 5+ hours of inspiration and information. It's available to watch on YouTube.
Plano’s Tyler Technologies acquired Pennsylvania-based CODY Systems, a software and data management, integration and exchange solutions company serving public safety, law enforcement and other public sector entities.
Tyler said the deal adds cloud-based records management and data-sharing tools to its public safety portfolio....
Addison-based Solenic Medical won a patent for technology that uses alternating magnetic fields to fight infections on metallic medical implants. Its alternating magnetic field technology is at the core of a treatment platform the company is now moving into a pivotal clinical trial....
Plano’s Tyler Technologies acquired Pennsylvania-based CODY Systems, a software and data management, integration and exchange solutions company serving public safety, law enforcement and other public sector entities.
Tyler said the deal adds cloud-based records management and data-sharing tools to its public safety portfolio....
Addison-based Solenic Medical won a patent for technology that uses alternating magnetic fields to fight infections on metallic medical implants. Its alternating magnetic field technology is at the core of a treatment platform the company is now moving into a pivotal clinical trial....